CDKN2B and cervical cancer: The results showed that CDKN2B-AS1, MIR205HG, and HAGLROS were highly expressed in cervical cancer (Figures 5A–C), whereas GATA6-AS1 and DICER1-AS1 showed low expression levels in cervical cancer (Figures 5D,E).